Chondrogenic potential of mesenchymal cells elicited by bone matrix in vitro.
Demineralized bone matrix (DBM) induces development of bone in vivo via the endochondral mode of development. Early events in this inductive process involve the appearance of mesenchymal cells (day 3) followed by chondrogenic differentiation (day 7) after subcutaneous implantation of DBM. In this investigation the chondrogenic potential in vitro of day 3 and day 4 mesenchymal cells from a DBM-induced implant has been explored. Immunofluorescent examination of day 3 cell cultures maintained for 4 days revealed the presence of type II collagen and cartilage-specific proteoglycans only in spherical or polyhedral cells. Micromass cultures and agarose suspension cultures showed toluidine-blue metachromasia in only a small population of cells. Biochemical estimation of 35SO4-labeled proteoglycans from suspension cultures of day 3 and day 4 cells maintained for 3 days indicated the presence of 29% and 38% large cartilage-specific proteoglycans, respectively. Addition of bone-inductive guanidine extract of DBM to the cultures did not significantly increase the percentage of large proteoglycans. These observations suggest that day 3 and day 4 cells can undergo chondrogenic differentiation in vitro without the continued presence of the bone-inductive guanidine extract. The presence of guanidine extract in cultures did not enhance chondrogenic expression or promote the recruitment of mesenchymal cells and their transformation to the chondrogenic phenotype.